NIVISNEBART
UNII YRU8TD2FZD

Substance Identification & Data

This profile provides standardized clinical and technical data for Nivisnebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YRU8TD2FZD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923556-87-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YRU8TD2FZD

CAS Registry Number

2923556-87-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NIVISNEBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211831

National Cancer Institute reference terminology for clinical and research data.

INN ID

13157

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-180

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nivisnebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NIVISNEBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-459) (VH (HOMO SAPIENS IGHV1-46*01 (96.9%) -(IGHD) -IGHJ6*01 (94.1%), CDR-IMGT (8.8.22) (26-33.51-58.97-118)) (1-129) -HOMO SAPIENS IGHG1*01, G1M17,1 CH1 K120, CH3 D12, L14, G1V40 CH2 A1.3, A1.2, S116 (CH1 K120 (226) (130-227), HINGE 1-15 (228-242), CH2 L1.3>A (246), L1.2>A (247), P116>S (343) (243-352), CH3 D12 (368), L14 (370) (353-457), CHS (458-459)) (130-459)), (232-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (100%) -IGKJ4*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (238-238'':241-241'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (246-ALANINE,247-ALANINE,343-SERINE), ANTI-(HUMAN SORTILIN) (RECOMBINANT HUMAN MONOCLONAL S-15-10-7 ALLOTYPE G1M17(1) .GAMMA.1-CHAIN), DISULFIDE WITH RECOMBINANT HUMAN MONOCLONAL S-15-10-7 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SORT1 (SORTILIN 1, GP95, NT3)), HOMO SAPIENS MONOCLONAL ANTIBODY;

NIVISNEBART [INN]

NIVISNEBART [USAN]